# Koniku

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/koniku

- Industry: Biotechnology
- Headquarters: San Rafael, US
- Website: www.koniku.com
- Latest round: Series A (Dec 17, 2021)
- Investors on record: 4

## About

Koniku Inc. is a biotechnology firm focused on integrating biological neurons into innovative co-processors, enhancing security, military applications, and agricultural solutions through autonomous learning technologies.Founded in 2015 in San Rafael, US, Koniku Inc. develops neuron-based technologies for various industries. The company has pivoted its focus to incorporate advanced detection systems, enhancing its offerings across security and agriculture. The founder, Christopher H, has a background that includes previous entrepreneurial ventures. Notably, the firm has successfully completed 4 funding rounds, with the latest round enabling significant investment in its future strategies. SOSV and Indie Bio have exited their investment in Koniku.Koniku® specializes in developing innovative co-processors utilizing biological neurons that autonomously learn from sensory inputs. Their core products enhance security measures, including advanced airport security systems to detect threats before checkpoints, drones for locating buried IEDs, and devices for quality assurance in agriculture. With the ability to create tailored receptors through DNA sequencing, Koniku addresses specific industry challenges across defense, airport security, and agriculture globally, serving a diverse clientele from governmental bodies to commercial enterprises in North America, Europe, and Asia.Koniku generates revenue primarily through business-to-business transactions with governments, military organizations, and commercial entities in security and agriculture. Their revenue model includes direct sales of proprietary neuron-based technologies and potential licensing agreements. The company's flagship offerings, particularly in security and military applications, command premium pricing due to their innovative nature and critical application, with a focus on long-term contracts and client collaboration ensuring comprehensive deployment and support.Koniku plans to enhance its product line with new innovative technologies aimed at improving their existing offerings. The company is targeting expansion into additional markets, specifically within Europe and Asia, by 2025. Recent funding will be allocated to support these initiatives, including research and development for upcoming products designed to meet the specific demands of these regions.

## Funding rounds

- Series A, Dec 17, 2021 — Platform Capital
- Seed, Aug 15, 2021 — LoftyInc Capital Management
- Seed, Sep 7, 2015 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed
- LoftyInc Capital Management (https://capitalatlas.ai/funds/loftyinc-capital-management) — Seed
- Platform Capital — Series A